111 related articles for article (PubMed ID: 6278462)
1. [Use of glucocorticoid preparations in congenital adrenocortical dysfunction].
Zelenetskaia VS; Kolesnikova GS; Romazanovich IG; Kuznetsova ES
Probl Endokrinol (Mosk); 1982; 28(1):38-42. PubMed ID: 6278462
[TBL] [Abstract][Full Text] [Related]
2. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
3. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
4. Single dose dexamethasone in treatment of congenital adrenocortical hyperplasia.
Hayek A; Crawford JD; Bode HH
Metabolism; 1971 Sep; 20(9):897-901. PubMed ID: 4327743
[No Abstract] [Full Text] [Related]
5. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M; Mallappa A; Gounden V; Nella AA; Harrison RF; Crutchfield CA; Backlund PS; Soldin SJ; Ross RJ; Merke DP
Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
[TBL] [Abstract][Full Text] [Related]
6. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
7. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical responsiveness to the synthetic ACTH 1-17 analogue given at different circadian stages.
Ferrari E; Bossolo PA; Carnevale Schianca GP; Solerte SB; Fioravanti M; Nascimbene M
Chronobiologia; 1982; 9(2):133-41. PubMed ID: 6288331
[TBL] [Abstract][Full Text] [Related]
9. [Corticosteroid and ACTH levels in relation to the age and sex of children with congenital adrenocortical dysfunction].
Kolesnikova GS; Pankova SS; Kuznetsova ES
Probl Endokrinol (Mosk); 1984; 30(5):49-53. PubMed ID: 6095256
[TBL] [Abstract][Full Text] [Related]
10. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
Hughes IA; Read GF
Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
[TBL] [Abstract][Full Text] [Related]
11. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
Richards GE; Grumbach MM; Kaplan SL; Conte FA
J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
Kier A; Han J; Jacobson L
Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
[TBL] [Abstract][Full Text] [Related]
13. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
Frisch H; Parth K; Schober E; Swoboda W
Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
[TBL] [Abstract][Full Text] [Related]
14. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
Loras B; Roux H; Audi-Parera L; David M; Bertrand J
Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
[No Abstract] [Full Text] [Related]
15. Circadian timing of ACTH, beta endorphin, adrenal steroids and testosterone in patients with adrenogenital syndrome (21-hydroxylase deficiency).
Nicolau GY; Haus E; Marinescu I; Lakatua D; Popa M; Sackett-Lundeen L; Petrescu E
Prog Clin Biol Res; 1990; 341A():483-91. PubMed ID: 2170988
[No Abstract] [Full Text] [Related]
16. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
Silva IN; Oliveira-Júnior DF; Simal CJ; Viana MB; Chagas AJ
Indian J Pediatr; 1994; 61(4):341-6. PubMed ID: 8002061
[TBL] [Abstract][Full Text] [Related]
17. Androgens levels in plasma and urine of patients with virilizing congenital adrenal hyperplasia.
Rudd BT; Rayner PH
Proc R Soc Med; 1970 Oct; 63(10):1039-40. PubMed ID: 4320706
[No Abstract] [Full Text] [Related]
18. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
McKenna TJ; Jennings AS; Liddle GW; Burr IM
J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
[TBL] [Abstract][Full Text] [Related]
19. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
Ross RJ; Rostami-Hodjegan A
Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
[TBL] [Abstract][Full Text] [Related]
20. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
